Evaluate the efficacy, safety and tolerability of SeRelaxin when added to standard therapy in acute Heart Failure patients – Harris/DOM
Active
Purpose
Start Date
July, 2013
End Date
July 2017
Investigator(s)
Rachael Harris, MD
Interventions
Other:
Drug:
Drug:
Eligibility